Search

Your search keyword '"Juanitez, Anna Marie"' showing total 5 results
Start Over Author "Juanitez, Anna Marie" Search Limiters Full Text
5 results on '"Juanitez, Anna Marie"'

1. Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed and Refractory Follicular Lymphoma: Analysis of Safety, Efficacy, and Minimal Residual Disease

Author

Melani, Christopher, primary, Lakhotia, Rahul, additional, Pittaluga, Stefania, additional, Phelan, James D., additional, Simard, Jillian, additional, Muppidi, Jagan R., additional, Thomas, Craig J., additional, Ceribelli, Michele, additional, Tosto, Frances Anne, additional, Farah, Rafic J., additional, Lee, Seung Tae, additional, Pradhan, Amynah, additional, Juanitez, Anna Marie, additional, Steinberg, Seth M., additional, Jaffe, Elaine S., additional, Roschewski, Mark, additional, Staudt, Louis M., additional, and Wilson, Wyndham H., additional

Published
2022
Full Text
View/download PDF

2. Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-Cell Lymphoma: Preliminary Analysis of Safety and Efficacy

Author

Melani, Christopher, primary, Lakhotia, Rahul, additional, Pittaluga, Stefania, additional, Phelan, James D., additional, Simard, Jillian, additional, Muppidi, Jagan R., additional, Thomas, Craig J., additional, Ceribelli, Michele, additional, Tosto, Frances Anne, additional, Pradhan, Amynah, additional, Juanitez, Anna Marie, additional, Steinberg, Seth M., additional, Jaffe, Elaine S., additional, Roschewski, Mark, additional, Staudt, Louis M., additional, and Wilson, Wyndham H., additional

Published
2022
Full Text
View/download PDF

3. Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory and Untreated Mantle Cell Lymphoma: Safety, Efficacy, and Molecular Analysis

Author

Melani, Christopher, primary, Lakhotia, Rahul, additional, Pittaluga, Stefania, additional, Miljkovic, Milos D., additional, Phelan, James D., additional, Muppidi, Jagan R., additional, Thomas, Craig J., additional, Ceribelli, Michele, additional, Juanitez, Anna Marie, additional, Pradhan, Amynah, additional, Hillsman, Amy, additional, Steinberg, Seth M., additional, Jaffe, Elaine S., additional, Roschewski, Mark, additional, Staudt, Louis M., additional, and Wilson, Wyndham H., additional

Published
2021
Full Text
View/download PDF

4. Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Author

Melani, Christopher, primary, Lakhotia, Rahul, additional, Pittaluga, Stefania, additional, Miljkovic, Milos D., additional, Phelan, James D., additional, Muppidi, Jagan R., additional, Thomas, Craig J., additional, Ceribelli, Michele, additional, Tosto, Frances Anne, additional, Portell, Craig A., additional, Farah, Rafic J., additional, Lee, Seung Tae, additional, Juanitez, Anna Marie, additional, Steinberg, Seth M., additional, Jaffe, Elaine S., additional, Roschewski, Mark, additional, Staudt, Louis M., additional, and Wilson, Wyndham H., additional

Published
2020
Full Text
View/download PDF

5. Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Author

Melani, Christopher, primary, Lakhotia, Rahul, additional, Pittaluga, Stefania, additional, Miljkovic, Milos D., additional, Muppidi, Jagan R., additional, Portell, Craig A., additional, Farah, Rafic, additional, Lee, Seung Tae, additional, Juanitez, Anna Marie, additional, Chou, Lydia L., additional, Steinberg, Seth M., additional, Jaffe, Elaine S., additional, Staudt, Louis, additional, Roschewski, Mark, additional, and Wilson, Wyndham, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results